178 related articles for article (PubMed ID: 7625786)
1. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Stuht H; Lode H; Koeppe P; Rost KL; Schaberg T
Antimicrob Agents Chemother; 1995 May; 39(5):1045-9. PubMed ID: 7625786
[TBL] [Abstract][Full Text] [Related]
2. Lack of interaction between lomefloxacin and caffeine in normal volunteers.
Healy DP; Schoenle JR; Stotka J; Polk RE
Antimicrob Agents Chemother; 1991 Apr; 35(4):660-4. PubMed ID: 2069371
[TBL] [Abstract][Full Text] [Related]
3. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
Mant TG
Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.
Robson RA; Begg EJ; Atkinson HC; Saunders DA; Frampton CM
Br J Clin Pharmacol; 1990 Apr; 29(4):491-3. PubMed ID: 2328197
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
Velpandian T; Gupta SK; Gupta YK; Agarwal HC; Biswas NR
J Ocul Pharmacol Ther; 1999 Dec; 15(6):505-11. PubMed ID: 10609773
[TBL] [Abstract][Full Text] [Related]
6. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
Mahr G; Sörgel F; Granneman GR; Kinzig M; Muth P; Patterson K; Fuhr U; Nickel P; Stephan U
Clin Pharmacokinet; 1992; 22 Suppl 1():90-7. PubMed ID: 1319876
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and safety of single oral doses of lomefloxacin.
Morse IS
Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
[TBL] [Abstract][Full Text] [Related]
10. Lomefloxacin clinical pharmacokinetics.
Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
Lebrec D; Gaudin C; Benhamou JP
Am J Med; 1992 Apr; 92(4A):41S-44S. PubMed ID: 1316069
[TBL] [Abstract][Full Text] [Related]
12. Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen metabolism in healthy subjects by positron emission tomography.
Bednarczyk EM; Green JA; Nelson AD; Leisure GP; Little D; Adler LP; Berridge MS; Panacek EA; Miraldi FD
Pharmacotherapy; 1992; 12(5):369-75. PubMed ID: 1331992
[TBL] [Abstract][Full Text] [Related]
13. Renal clearance of lomefloxacin is decreased by furosemide.
Sudoh T; Fujimura A; Shiga T; Sasaki M; Harada K; Tateishi T; Ohashi K; Ebihara A
Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
[TBL] [Abstract][Full Text] [Related]
14. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
Symonds WT; Nix DE
Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of lomefloxacin following multiple doses.
Hunt TL; Adams MA
Diagn Microbiol Infect Dis; 1989; 12(2):181-7. PubMed ID: 2752716
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of lomefloxacin as compared with ciprofloxacin.
Inderlied CB; Lancero MG; Bermudez LM; Young LS
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):17S-20S. PubMed ID: 2791493
[TBL] [Abstract][Full Text] [Related]
17. Effect of ranitidine on renal clearance of lomefloxacin.
Sudoh T; Fujimura A; Harada K; Sunaga K; Ohmori M; Sakamoto K
Eur J Clin Pharmacol; 1996; 51(1):95-8. PubMed ID: 8880059
[TBL] [Abstract][Full Text] [Related]
18. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
Wijnands GJ; Cornel JH; Martea M; Vree TB
Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin.
Washington C; Hou E; Hughes N; Berner B
Am J Health Syst Pharm; 2006 Apr; 63(7):653-6. PubMed ID: 16554289
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects.
Ferguson J; McEwen J; Al-Ajmi H; Purkins L; Colman PJ; Willavize SA
J Antimicrob Chemother; 2000 Apr; 45(4):503-9. PubMed ID: 10747828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
